Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Capital Expenditures (2017 - 2021)

Historic Capital Expenditures for Cogent Biosciences (COGT) over the last 4 years, with Q4 2021 value amounting to $433000.0.

  • Cogent Biosciences' Capital Expenditures changed N/A to $433000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2025, which is 17120.42% up from last year.
  • Latest data reveals that Cogent Biosciences reported Capital Expenditures of $433000.0 as of Q4 2021.
  • Over the past 5 years, Cogent Biosciences' Capital Expenditures peaked at $1.2 million during Q3 2021, and registered a low of -$22000.0 during Q3 2019.
  • Over the past 4 years, Cogent Biosciences' median Capital Expenditures value was $162500.0 (recorded in 2017), while the average stood at $257500.0.
  • As far as peak fluctuations go, Cogent Biosciences' Capital Expenditures surged by 6359.45% in 2018, and later crashed by 12558.14% in 2019.
  • Over the past 4 years, Cogent Biosciences' Capital Expenditures (Quarter) stood at $100000.0 in 2017, then dropped by 14.0% to $86000.0 in 2018, then crashed by 84.88% to $13000.0 in 2019, then soared by 3230.77% to $433000.0 in 2021.
  • Its last three reported values are $433000.0 in Q4 2021, $1.2 million for Q3 2021, and $13000.0 during Q4 2019.